$34.37
Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Omnicell President Sells 6,753 Shares
Overview
52-week range
$29
$55
20% of range
Avg surprise (last 2)
+309.1%
Avg reaction (last 1)
-15.8%
0% positive
Latest IV / EM
20%
EM ±3.2% · $35 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.52 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $0.25 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.12 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $0.24 | $0.11 | +118.2% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.08 | $-0.02 | +500.0% | — | -15.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.19 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.34 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.12 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.08 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.33 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $312M | $310M | — | $311M | $291M | $270M | — | $282M |
| Cost of revenue | $159M | $170M | — | $176M | $163M | $159M | — | $160M |
| Gross profit | $153M | $140M | — | $135M | $128M | $111M | — | $122M |
| Operating income | $32M | $17M | — | $8M | $8M | $-12M | — | $7M |
| Net income | $24M | $11M | — | $5M | $6M | $-7M | — | $9M |
| EPS (diluted) | $0.52 | $0.25 | — | $0.12 | $0.12 | $-0.15 | — | $0.19 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $292M | $239M | $197M | $180M | $399M | $387M | $369M | $571M |
| Inventory | $97M | $99M | $101M | $107M | $106M | $91M | $89M | $95M |
| Total current assets | $735M | $722M | $680M | $660M | $845M | $840M | $815M | $1.01B |
| Total assets | $2.00B | $2.00B | $1.97B | $1.95B | $2.15B | $2.15B | $2.12B | $2.30B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $707M | $747M | $743M | $728M | $882M | $894M | $878M | $1.07B |
| Total equity | $1.29B | $1.26B | $1.23B | $1.22B | $1.26B | $1.26B | $1.24B | $1.23B |